Key Points
-
The introduction of transcatheter aortic valve implantation (TAVI) has substantially changed the treatment of aortic stenosis in high-risk surgical patients in the past 10 years
-
Problems with the first-generation TAVI devices include increased rates of vascular complications, neurological events, rhythm disturbances, and paravalvular leakage
-
The extension of TAVI to young and low-risk patients with aortic stenosis requires further technological improvements
-
New-generation TAVI devices specifically designed to overcome the limitations of the first-generation devices are currently in the early stages of clinical evaluation
Abstract
Treatment of aortic stenosis in high-risk surgical patients has been modified in the past 10 years owing to the introduction of transcatheter aortic valve implantation (TAVI). Several issues affecting outcomes with implantation of the first-generation TAVI devices remain unresolved, including haemorrhagic and vascular complications, neurological events, rhythm disturbances, and paravalvular leakage. Further technological improvements are, therefore, required before the indications for TAVI can be extended to young and low-risk patients with aortic stenosis. Many new-generation TAVI devices are currently in the early stages of clinical evaluation. Modifications in the new devices include the ability to reposition the valve before final deployment, features to reduce paravalvular leakage, and the introduction of low-profile delivery systems. The aim of this Review is to provide an overview of the new-generation transcatheter valvular technologies, including initial clinical reports.
Similar content being viewed by others
References
Cribier, A. et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 106, 3006–3008 (2002).
Vahanian, A. et al. Guidelines on the management of valvular heart disease (version 2012). Eur. Heart J. 33, 2451–2496 (2012).
Piazza, N. et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE marking approval. EuroIntervention 4, 242–249 (2008).
Tamburino, C. et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123, 299–308 (2011).
Thomas, M. et al. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 124, 425–433 (2011).
Thomas, M. et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122, 62–69 (2010).
Gilard, M. et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N. Engl. J. Med. 366, 1705–1715 (2012).
Leon, M. B. et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597–1607 (2010).
Smith, C. R. et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N. Engl. J. Med. 364, 2187–2198 (2011).
Hadjinikolaou, L. et al. Aspire porcine bioprosthesis: ten years' experience. J. Heart Valve Dis. 14, 47–53 (2005).
Flynn, M. et al. The aortic Elan stentless aortic valve: excellent hemodynamics and ease of implantation. Semin. Thorac. Cardiovasc. Surg. 13, 48–54 (2001).
Treede, H. et al. JenaValve. EuroIntervention 8 (Suppl. Q), Q88–Q93 (2012).
Rudolph, T. K. & Baldus, S. JenaValve—transfemoral technology. EuroIntervention 9 (Suppl. S), S101–S102 (2013).
Treede, H. et al. Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study. Eur. J. Cardiothorac. Surg. 41, e131–e138 (2012).
Ensminger, S. First results of the JUPITER Registry on long-term performance and safety of the transapical JenaValve. Presented at EuroPCR 2013.
Leon, M. B. et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J. Am. Coll. Cardiol. 57, 253–269 (2011).
Seiffert, M. et al. Transapical implantation of a second-generation transcatheter heart valve in patients with noncalcified aortic regurgitation. JACC Cardiovasc. Interv. 6, 590–597 (2013).
Kempfert, J., Möllmann, H. & Walther, T. Symetis ACURATE TA valve. EuroIntervention 8 (Suppl. Q), Q102–Q109 (2012).
Walther, T., Möllmann, H., van Linden, A. & Kempfert, J. Transcatheter aortic valve implantation transapical: step by step. Semin. Thorac. Cardiovasc. Surg. 23, 55–61 (2011).
Kempfert, J. et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA™): 6-month outcomes. Eur. J. Cardiothorac. Surg. 43, 52–56 (2013).
Abizaid, A. Symetis Transfemoral Technology. Presented at EuroPCR 2013.
Manoharan, G., Spence, M. S., Rodés-Cabau, J. & Webb, J. G. St Jude Medical Portico valve. EuroIntervention 8 (Suppl. Q), Q97–Q101 (2012).
Willson, A. B. et al. Transcatheter aortic valve replacement with the St. Jude Medical Portico valve: first-in-human experience. J. Am. Coll. Cardiol. 60, 581–586 (2012).
Urena, M., Doyle, D., Rodés-Cabau, J. & Dumont, E. Initial experience of transcatheter aortic valve replacement with the St Jude Medical Portico valve inserted through the transapical approach. J. Thorac. Cardiovasc. Surg. 146, e24–e27 (2013).
Bijuklic, K., Tübler, T., Low, R. I., Grube, E. & Schofer, J. Direct Flow Medical valve. EuroIntervention 8 (Suppl. Q), Q75–Q78 (2012).
Bijuklic, K. et al. Midterm stability and hemodynamic performance of a transfemorally implantable nonmetallic, retrievable, and repositionable aortic valve in patients with severe aortic stenosis. Up to 2-year follow-up of the direct-flow medical valve: a pilot study. Circ. Cardiovasc. Interv. 4, 595–601 (2011).
Schofer, J. Prospective, multicenter evaluation of the 18 Fr Direct Flow transcatheter aortic valve: the DISCOVER trial – final study enrollment. Presented at EuroPCR 2013.
Sündermann, S. H. et al. Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design. Eur. J. Cardiothorac. Surg. 42, e48–e52 (2012).
Falk, V. et al. Transapical aortic valve implantation with a self-expanding anatomically oriented valve. Eur. Heart J. 32, 878–887 (2011).
Holzhey, D. Thirty-day outcomes from the multicenter European pivotal trial for transapical transcatheter aortic valve implantation with a self-expanding prosthesis. Presented at EuroPCR 2013.
Sinning, J. M., Werner, N., Nickenig, G. & Grube, E. Medtronic CoreValve Evolut valve. EuroIntervention 8 (Suppl. Q), Q94–Q96 (2012).
Fairley, S. L., Jeganathan, R., Manoharan, G. & Spence, M. S. Early experience of implantation of the new CoreValve® Evolut™ in degenerated bioprosthetic aortic valves. Catheter. Cardiovasc. Interv. http://dx.doi.org/10.1002/ccd.25125.
Diemert, P. Valve-in-valve implantation of a novel and small self-expandable transcatheter heart valve in degenerated surgical bioprosthesis. The Hamburg experience. Presented at EuroPCR 2013.
Meredith, I. T., Hood, K. L., Haratani, N., Allocco, D. J. & Dawkins, K. D. Boston Scientific Lotus valve. EuroIntervention 8 (Suppl. Q), Q70–Q74 (2012).
Meredith, I. T. Thirty day outcome for the first 60 patients in the REPRISE II study. Presented at EuroPCR 2013.
Kappetein, A. P. et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur. Heart J. 33, 2403–2418 (2012).
Binder, R. K., Rodés-Cabau, J., Wood, D. A. & Webb, J. G. Edwards SAPIEN 3 valve. EuroIntervention 8 (Suppl. Q), Q83–Q87 (2012).
Binder, R. K. et al. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve. JACC Cardiovasc. Interv. 6, 293–300 (2013).
Ribeiro, H. B. et al. Transapical Implantation of the SAPIEN 3 Valve. J. Card. Surg. 28, 506–509 (2013).
Ribeiro, H. B., Urena, M., Kuck, K. H., Webb, J. G. & Rodés-Cabau, J. Edwards CENTERA valve. EuroIntervention 8 (Suppl. Q), Q79–Q82 (2012).
Binder, R. K. et al. Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system. JACC Cardiovasc. Interv. 6, 301–307 (2013).
Schäfer, U. Edwards CENTERA transcatheter heart valve. Presented at EuroPCR 2013.
Barbanti, M., Ye, J., Pasupati, S., El-Gamel, A. & Webb, J. G. The Helio transcatheter aortic dock for patients with aortic regurgitation. EuroIntervention 9 (Suppl. S), S91–S94 (2013).
Pasupati, S. A novel approach to aortic insufficiency: Edwards Helio System—feasibility trial. Presented at EuroPCR 2013.
Webb, J. Helio (Giovani): a dedicated transcatheter valve system for aortic insufficiency. Presented at EuroPCR 2013.
Abdel-Wahab, M. et al. German transcatheter aortic valve interventions registry investigators. Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97, 899–906 (2011).
Gotzmann, M. et al. Transcatheter aortic valve implantation in patients with severe symptomatic aortic valve stenosis-predictors of mortality and poor treatment response. Am. Heart J. 162, 238–245.e1 (2011).
Linke, A. One year outcome in real world patients treated with transcatheter aortic valve implantation: the ADVANCE study. Presented at EuroPCR 2013.
Leon, M. A randomized evaluation of the SAPIEN XT transcatheter valve system in patients with aortic stenosis who are not candidates for surgery: PARTNER II, inoperable cohort. Presented at the American College of Cardiology Scientific Sessions (2013).
Treede, H. One year outcomes from the SOURCE XT Registry: propensity score matching for transfemoral versus transapical approach. Presented at EuroPCR 2013.
Eggebrecht, H. et al. Risk of stroke after transcatheter aortic valve implantation (TAVI): a meta-analysis of 10,037 published patients. EuroIntervention 8, 129–138 (2012).
Windecker, S. One-year outcomes from the SOURCE XT post-approval study. Presented at EuroPCR 2013.
Emlein, G. et al. Prolonged bradyarrhythmias after isolated coronary artery bypass graft surgery. Am. Heart J. 126, 1084–1090 (1993).
Glikson, M. et al. Indications, effectiveness, and long-term dependency in permanent pacing after cardiac surgery. Am. J. Cardiol. 80, 1309–1313 (1997).
Van Mieghem, N. M. et al. Persistent annual permanent pacemaker implantation rate after surgical aortic valve replacement in patients with severe aortic stenosis. Ann. Thorac. Surg. 94, 1143–1149 (2012).
Wenaweser, P. et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur. Heart J. 34, 1894–1905 (2013).
US National Library of Medicine. ClinicalTrials.gov [online], (2013).
US National Library of Medicine. ClinicalTrials.gov [online], (2013).
Acknowledgements
We would like to thank the other members of the TAVI team at San Raffaele University Hospital—Dr Paolo Denti, Dr Micaela Cioni, and Dr Nicola Buzzatti—for their support.
Author information
Authors and Affiliations
Contributions
M. Taramasso researched data for the article, discussed its content, and wrote, reviewed, and edited the manuscript. A. Pozzoli researched data for the article, and wrote, reviewed, and edited the manuscript. A. Latib, G. La Canna, A. Colombo, F. Maisano, and O. Alfieri discussed the content and reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Taramasso, M., Pozzoli, A., Latib, A. et al. New devices for TAVI: technologies and initial clinical experiences. Nat Rev Cardiol 11, 157–167 (2014). https://doi.org/10.1038/nrcardio.2013.221
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2013.221
- Springer Nature Limited
This article is cited by
-
Stiff Composite Cylinders for Extremely Expandable Structures
Scientific Reports (2019)
-
On the Mechanics of Transcatheter Aortic Valve Replacement
Annals of Biomedical Engineering (2017)